Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000671655 | SCV000796650 | pathogenic | Ellis-van Creveld syndrome | 2017-12-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000807466 | SCV000947519 | pathogenic | Ellis-van Creveld syndrome; Curry-Hall syndrome | 2018-09-13 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in EVC are known to be pathogenic (PMID: 23220543). This variant has been observed in two individuals affected with Ellis-van Creveld syndrome (PMID: 23220543). ClinVar contains an entry for this variant (Variation ID: 555774). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Glu354Serfs*31) in the EVC gene. It is expected to result in an absent or disrupted protein product. |
Natera, |
RCV000671655 | SCV001454802 | pathogenic | Ellis-van Creveld syndrome | 2020-09-16 | no assertion criteria provided | clinical testing |